{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Pennington",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "73221",
      "recalling_firm": "Zydus Pharmaceuticals USA Inc",
      "address_1": "73 Route 31 N",
      "address_2": "N/A",
      "postal_code": "08534-3601",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US Nationwide including Puerto Rico",
      "recall_number": "D-0725-2016",
      "product_description": "risperiDONE ORALLY DISINTEGRATING TABLETS, 2 mg, 30 Ct Bottles, Rx Only. Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India.  Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ  08534. NDC: 68382-156-06.",
      "product_quantity": "9504 Bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for a known degradant.",
      "recall_initiation_date": "20160114",
      "center_classification_date": "20160222",
      "termination_date": "20201218",
      "report_date": "20160302",
      "code_info": "Lot #: MP4967, Expiry: 04/2016.",
      "more_code_info": ""
    }
  ]
}